Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of Nasacort AQ on Growth Velocity in Children with Perennial Allergic Rhinitis
NCT00449072Phase 4Completed
- Sponsor
- Sanofi
- Start
- Mar 2007
- Primary completion
- Oct 2011
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of triamcinolone acetonide in perennial allergic rhinitis (PAR), sponsored by Sanofi. Started Mar 2007; status: completed.
02
Drugs
triamcinolone acetonide
03
Conditions
perennial allergic rhinitis (PAR)
Beyond the preview
Go deeper on NCT00449072.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00449072.